Early impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis-Burkina Faso, 2014-2015

Authors

Kambiré D, Soeters HM, Ouédraogo-Traoré R, Medah I, Sangaré L, Yaméogo I, Sawadogo G, Ouédraogo AS, Ouangraoua S, McGee L, Srinivasan V, Aké F, Congo-Ouédraogo M, Ky Ba A, Whitney CG, Novak RT, Van Beneden C, MenAfriNet Consortium

Journal

J Infect

Volume

76

Issue

3

Pages

270-279

Publication year

2018

Suggested citation

Kambiré D, Soeters HM, Ouédraogo-Traoré R, Medah I, Sangaré L, Yaméogo I, Sawadogo G, Ouédraogo AS, Ouangraoua S, McGee L, Srinivasan V, Aké F, Congo-Ouédraogo M, Ky Ba A, Whitney CG, Novak RT, Van Beneden C, MenAfriNet Consortium. Early impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis-Burkina Faso, 2014-2015. J Infect. 2018; 76(3): 270-279.

DOI

10.1016/j.jinf.2017.12.002

PMID

29253559

Header sites

Search form

Main menu

Early impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis-Burkina Faso, 2014-2015

Nav